In April 2005 the new contractual framework for community pharmacy ("the new contract") was introduced in the UK. In addition to traditional dispensing duties pharmacists were invited to participate in a new service, the medicines used review (MUR).
The MUR involves pharmacists undertaking structured concordance centered reviews with patients on multiple medicines, particularly those receiving medicines for long term conditions. The pharmacist consults with the patient to establish the patients actual use of medicines compared to the posology of their prescription. The review aims to help patients understand their therapy, identify any problems they are experiencing along with possible solutions. For this review to be most effective it is essential that pharmacists feedback information on the outcomes from the MUR to the patientâs GP so that both healthcare professionals have the same information available to them and act similarly if compliance is to be optimized.
In this study of 400 GPs we examined the interactions between GPs and pharmacists, GPs familiarity with MURs and their impact on patient care. The results will be explored at the Patient Compliance & Communication conference, June 11-12th 2008.
The early bird discount of €300 to this world-leading meeting expires March 5th, in just one weeks time. To register at this special price visit https://secure.firstconf.com/pharma/pceu2008/register.htm.
The full detailed brochure of all other presentations is available to download now at http://www.eyeforpharma.com/pceu2008/
eyeforpharma is a leading global source of information for the pharmaceutical industry. Our reputation has been built on quality, in-depth conferences that have distinguished themselves from competitors by the depth and breadth of research we put into each conference to ensure it is covering the hottest and most pertinent issues of the industry. Months are spent talking directly to senior executives in the industry, as well as relevant consultants and journalists and well respected solutions providers.
eyeforpharma also provides a fortnightly newsletter to over 11 thousand leading executives from every major pharmaceutical company in the industry, and of course consultants, sponsors and academics as well.
The eyeforpharma wiki, launched last month, highlights our dedication to improving the communication between people in the industry and furthering learning and development within it.
For further information, please visit www.eyeforpharma.com.